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Abstract Alpha-1-antitrypsin (AAT) deficiency is a rare
genetic disorder characterized by hepatitis in neonates,
childhood and adulthood (protease inhibitor (PI)*ZZ) and
emphysema with or without hepatitis (PI*ZZ)/(PI*SS,SZ or
null) in adulthood. We report the case of a female neonate
born at 40 weeks of gestation who presented with
vitamin K deficiency-related intracranial bleeding and
cholestasis of which she died at 28 days of age. At autopsy,
the infant was found to have intracranial bleeding,
hepatomegaly, and cholestasis with paucity of bile ducts
in the liver. Small periodic acid-Schiff diastase positive
intrahepatic granules and positive staining with antibodies
against AAT protein suggested an AAT deficiency. AAT is
a glycoprotein that has a protease inhibitor function. Its
deficiency can be the result of various point mutations in
Serpin 1 located on chromosome 14. The diagnosis AAT
deficiency was confirmed by mutation analysis showing the
PI*ZZ genotype in the neonate. In conclusion, AAT
deficiency is a rare genetic disorder that can lead to a serious
bleeding disorder in the neonatal period if not recognised on
time. Pathological diagnosis together with verifying molec-
ular analysis can be used to identify index patients.
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Introduction
Alpha-1-antitrypsin (AAT) deficiency, an autosomal recessive
disorder, is caused by inheritance of two severe deficient
alleles of Serpin 1 (located on chromosome 14q31-32)
encoding AAT [2]. AAT is a protease inhibitor with three
β-sheets and eight α-helices. The reactive loop site in the
β-sheet contains the neutrophil elastase binding site with a
methionine residue [3]. The protease inhibitor (PI)*MM
wild-type allele is the most prevalent normal allele and has
many variants [2]. The most important pathogenic PI*S
and PI*Z variants show mutations Glu264Val and
Glu342Lys, respectively, whereas PI*null variant has no
protein production. The patient can be homozygous or
compound heterozygous for pathogenic variants. The
protein product contains variable amounts of abnormal
polymers of AAT molecules which retain in the endoplasmic
reticulum (ER) in the liver. These retained abnormal polymers
can lead to hepatic cell injury and result in haemorrhagic
disease and or cholestasis in infancy and chronic liver disease
in childhood or adulthood. In addition, the uninhibited action
of the neutrophil elastase in the lungs can cause alveolar
damage resulting in emphysema in adulthood [3].
The highest PI*Z variant prevalence was recorded in
northern and western Europe (mean gene frequency, 0.0140)
[9]. Persons with the PI*ZZ phenotype have 10–15% of
normal AAT plasma levels. About 12% of ZZ infants
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develop neonatal hepatitis and cholestasis within the first
month of life [5]. The presenting symptom in neonates can
vary from harmless-looking (warning) bleeds or earlier
recognised jaundice to cholestasis and full-blown bleeding
diathesis with dramatic consequences [4, 6, 11].
To diagnose AAT deficiency, three different methods can
be used—level testing in blood, Pi-typing (phenotyping)
and genotyping. Level testing is not specific, phenotyping
shows the mutated protein and genotyping detects the
common selected mutations [1].
Case report and results
A 4-week-old baby girl was admitted to the neonatology
department of our hospital because of respiratory insufficiency,
convulsion and a large intracranial bleeding. She was the
second child of healthy non-consanguineous parents born
after an uneventful pregnancy and delivery at 40-weeks
gestational age. Family history yielded no important
diseases. Neonatal screening in the first week showed no
abnormalities. Vitamin K prophylaxis was given at birth
and until hospital administration according to the
standard Dutch protocols [10]. From birth, she was only
breastfed. Two weeks after birth, minimal rectal blood loss
was noted. This was considered by the referral hospital to
be due to cow milk allergy. The mother was instructed to
follow a cow milk protein-free diet for herself. In the
following weeks, oozing of the umbilical cord and
bruising of the palate were noted. Both symptoms were
reported separately and considered not to be alarming by
the different general physicians. Nearly 4 weeks after birth she
became lethargic, started vomiting and refused breastfeeding.
She was referred to the emergency department of the referral
hospital. At first, an infection was suspected for which
intravenous antibiotics were started. A few hours after
admission, convulsion started. Phenobarbital was administered.
She became respiratory insufficient for which she was
intubated, ventilated and transported to our university hospital.
We saw a pale hypotonic neonate with a bulging tense
fontanel without palpable pulses. Pupils were dilated with
hardly a reaction to light. Laboratory results revealed total
bilirubin, 85 μmol/L; conjugated bilirubin, 58μmol/L; ASAT,
94 U/L; ALAT, 40 U/L; haemoglobin, 4.6 mmol/L;
thrombocytes, 388×109/L; prothrombin time (PT), >100 s
and partial thromboplastin time (PTT), >300 s. Vitamin K-
dependent clotting factors were all below 40%. Because
factor V and factor VIII levels at the same time were 160%
and 200%, respectively, clinical Vitamin K-dependent bleeding
disorder (VKDBD) was suspected. Vitamin K (1 mg) was
given intravenously and within 2-h PTand PTT times, factor V
and factor VIII levels normalized. CT scan showed large
intraventricular bleedings on both sides and a large
intraparenchymal bleeding in the left temporal lobe with
severe oedema. An emergency external ventricular drainage
was performed. Postoperatively, there was no improvement in
her clinical condition. Pupils were dilated and non-responsive.
No cornea reflex could be evoked. Treatment was withdrawn,
and she died 1 day after admission.
Differential diagnosis for the background pathology leading
to cholestasis, liver dysfunction and further VKDBD was
biliary atresia, alpha-1-antitrypsin deficiency, cystic fibrosis,
inborn error in bile acid synthesis, haematochromatosis, liver
pathology such as viral neonatal hepatitis or one of rare
autosomal recessive forms of vitamin K-dependent clotting
factor deficiency 1 and 2.
Pathology
Autopsy
Both parents gave informed consent for complete autopsy.
At brain autopsy, left temporal lobe showed haemorrhage
with intraventricular extension. This resulted in increased
intracranial pressure and herniation of the cerebellar tonsils.
At body autopsy, the liver was greenish-brown showing bile
staining by cholestasis. The gallbladder, the extrahepatic bile
ducts and the papilla of Vater could be identified and opened.
The mucosal lining showed bile staining. With these findings
we excluded biliary atresia macroscopically. The new
pathologic differential diagnosis for the primary source of
the problems leading to VKDBD in this patient was neonatal
hepatitis/viral neonatal hepatitis, haematochromatosis or
AAT deficiency.
Microscopy
Microscopic examination of the liver displayed acute hepatitis
with portal tracts showing a mixed inflammatory reaction with
variable destruction of bile ducts and infiltration of the
parenchyma. Slight fibrosis with septum formation was
present. There was intraductal and intracanalicular cholestasis.
The parenchyma showed individual hepatocyte necrosis with
accumulation of waste products, bile and iron in hepatocytes
and Kupfer cells. Among the waste products were fine
cytoplasmic granules located especially in the periportal
hepatocytes which stained with periodic acid-Schiff (PAS)
before and after diastase pretreatment (Fig. 1). These PAS (+)
granules were not abundant enough to diagnose the primary
pathology with certainty; however, suspicion rose on AAT
deficiency.
The additional immunohistochemical anti-cytokeratin 7
and anti-cytokeratin 19 stainings (Biogenex) showed focal
paucity of the premature and mature bile ducts, respectively.
This paucity could be due to periductal inflammation and
cholestasis. Finally, anti-AAT protein staining (DAKO,
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concentration 1/40,000 without antigen retrieval in DAKO
immunostainer) showed clearly the accumulation of AAT
protein polymers in the hepatocytes (Fig. 2).
Microbiology
PCR studies to identify viral agents showed no cytomegalo-
virus in liver. Additional studies in microbiology showed no
growth of bacterial of viral agents.
Molecular analysis
Genomic DNA from peripheral bloods cells was isolated
according to standard procedures. Mutation analysis of
Serpin 1 was performed by direct sequence analysis of the
coding exons (2–5; exon 2 split into two). Primers, con-
taining an M13 tail, used were:
Exon 2-1 Forward: 5′ cacttccacgtggtgtcaat
Reverse: 5′ ggttgagggtacggaggagt
Exon 2-2 Forward: 5′ ttcttctccccagtgagcat
Reverse: 5′ gaatccacgctgaaaagcat
Exon 3 Forward: 5′ ggaggggactcatggtttct
Reverse: 5′ tagcagtgacccagggatgt
Exon 4 Forward: 5′ tagtgtgggtggaggacaca
Reverse: 5′ cagcctgggtcttcatttgt
Exon 5 Forward: 5′ gtccacgtgagccttgct
Reverse: 5′ ggaccagctcaacccttctt
PCR reactions were performed using standard conditions
(25-μL reaction, containing 100-ng genomic DNA; 2′ at
94°C, followed by 29 cycles of 30″ at 94°C, 30″ at 60°C
and 30″ at 72°C and a final extension of 10′ at 72°C).
Sequence analysis of exon 5 of Serpin 1 showed a
homozygous pattern for p.Glu342Lys in our patient. In
agreement with the homozygous pattern, the parents of the
patient were heterozygous for this pathogenic mutation.
Discussion
Alpha-1-antitrypsin (AAT) deficiency has an incidence of
0.05% and can be caused by homozygosity for PI*Z [9].
The mutant Z protein can form abnormal polymers of AAT
within the rough ER of hepatocytes. Chains of these polymers
become interwoven to form insoluble inclusions resulting in
reduced levels of this protein in the bloodstream. These
inclusions form the hallmark of AAT deficiency in pathological
diagnosis [8]. Clinical progression to liver disease is complex,
with Z allele homozygous neonates developing hepatitis and
cholestasis in about 10% of the cases [5]. Here, we reported
our findings in a 4-week-old female neonate who showed
harmless-looking warning bleeds at the age of 2 weeks
and cascade of complications leading to her death as a
result of intracranial VKDBD under standard vitamin K
prophylaxis [10].
Although VKDB is described earlier as a complication
of AAT deficiency in neonates, there are still two important
lessons we can learn from this patient.
The clinical lesson is the importance of early recognition
of the warning bleeds or the cholestasis. Various reports
showed a correlation between cholestasis and VKDB due to
fat malabsorption. It is also reported that adjustment of the
standard vitamin K prophylaxis protocols could prevent the
complications due to VKDB which also could have been
the case in this patient [12].
The diagnostic lesson is to use pathology as an instrument
in combination with verifying genotyping to diagnose AAT
deficiency. This statement contrasts with the earlier studies
where the cytoplasmic inclusions were not seen in children
Fig. 2 Immunohistochemical staining showing AAT protein deposition
in the hepatocyte (×200)
Fig. 1 PAS diastase positive granules in the hepatocytes. H & E, ×400
Eur J Pediatr (2011) 170:103–106 105
younger than 3 years [5, 7] or the false-positive results which
can be observed with immunohistochemistry in this age
group [7].
In conclusion, however, early recognition of the warning
bleeds or cholestasis, correct diagnosis using pathology as a
diagnostic instrument in addition to the existing methods and
adjustment of the standard vitamin K prophylaxis protocols
to prevent VKDB complications can be life saving in AAT
deficiency patients especially in the neonatal period.
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